Finland, May 15 -- Finland based BeOne Medicines, GmbH, Dutch Branch has secured contract from HUS Group, the joint authority for Helsinki and Uusimaa for Pharmaceutical products - Tislelitsumabin (Tevimbra) hankinta. The value of the contract is worth 100000000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....